MetLife Investment Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-25,773
| Closed | -$95.6K | – | 2789 |
|
2024
Q4 | $95.6K | Buy |
25,773
+20,474
| +386% | +$76K | ﹤0.01% | 2643 |
|
2024
Q3 | $17K | Sell |
5,299
-17,874
| -77% | -$57.2K | ﹤0.01% | 2829 |
|
2024
Q2 | $190K | Buy |
23,173
+5,157
| +29% | +$42.3K | ﹤0.01% | 2274 |
|
2024
Q1 | $261K | Hold |
18,016
| – | – | ﹤0.01% | 2048 |
|
2023
Q4 | $166K | Hold |
18,016
| – | – | ﹤0.01% | 2342 |
|
2023
Q3 | $297K | Hold |
18,016
| – | – | ﹤0.01% | 1962 |
|
2023
Q2 | $114K | Buy |
+18,016
| New | +$114K | ﹤0.01% | 2599 |
|
2023
Q1 | – | Sell |
-17,480
| Closed | -$101K | – | 2795 |
|
2022
Q4 | $101K | Hold |
17,480
| – | – | ﹤0.01% | 2589 |
|
2022
Q3 | $164K | Hold |
17,480
| – | – | ﹤0.01% | 2418 |
|
2022
Q2 | $390K | Hold |
17,480
| – | – | ﹤0.01% | 1837 |
|
2022
Q1 | $961K | Buy |
17,480
+6,464
| +59% | +$355K | 0.01% | 1352 |
|
2021
Q4 | $728K | Hold |
11,016
| – | – | 0.01% | 1291 |
|
2021
Q3 | $925K | Hold |
11,016
| – | – | 0.01% | 1154 |
|
2021
Q2 | $1.4M | Hold |
11,016
| – | – | 0.01% | 1012 |
|
2021
Q1 | $1.21M | Buy |
11,016
+563
| +5% | +$61.8K | 0.01% | 1066 |
|
2020
Q4 | $1.49M | Sell |
10,453
-1,056
| -9% | -$151K | 0.01% | 953 |
|
2020
Q3 | $812K | Hold |
11,509
| – | – | 0.01% | 1134 |
|
2020
Q2 | $805K | Buy |
11,509
+4,866
| +73% | +$341K | 0.01% | 1113 |
|
2020
Q1 | $232K | Hold |
6,643
| – | – | ﹤0.01% | 1610 |
|
2019
Q4 | $418K | Hold |
6,643
| – | – | ﹤0.01% | 1557 |
|
2019
Q3 | $223K | Hold |
6,643
| – | – | ﹤0.01% | 1882 |
|
2019
Q2 | $173K | Buy |
+6,643
| New | +$173K | ﹤0.01% | 2116 |
|